by searching electronic medical records and reviewing microbiology records for positive cultures. Cases were defined as those with a positive blood culture for Brucella sp, a serum agglutination titer ≥1:80 (or both positive blood culture and serum agglutination titer ≥1:80), along with an epidemiologic risk factor and clinical presentation that is consistent with brucellosis.
B
rucellosis is one of the most common zoonoses worldwide; its incidence is estimated to be 500,000 new cases per year. 1 Most cases of brucellosis in the United States are imported from endemic countries, particularly from Central or South America, the Mediterranean basin, the Arabian Gulf, and the Indian subcontinent. 2, 3 There are approximately 100 cases of brucellosis annually in the United States, 4 and more than half of these cases occur in California or Texas, predominantly in Hispanic patients. 1 Previous case series from California 5, 6 described the spectrum of clinical presentation of brucellosis in the United States. More recently, case reports from Chicago 7 and Dallas 8 have concentrated attention on how brucellosis presents in pediatric patients. Clinical manifestations of brucellosis are varied and nonspecific, which add to the difficulty in its diagnosis in both adults and children. Given the large immigrant population in Houston, Texas, we had the opportunity to describe brucellosis as it presents in two large tertiary care hospitals in the Texas Medical Center. The present study was designed to describe the epidemiology and clinical and laboratory features of brucellosis in adults and children in Houston.
Methods
We conducted a retrospective chart review of patients diagnosed as having brucellosis between January 2000 and December 2009. Cases were identified by searching electronic medical records and microbiology and infectious disease service databases for brucellosis (International Classification of Diseases, Ninth Revision code 0.239) inpatient and outpatient encounters at two tertiary care hospitals (Ben Taub Hospital, Harris Health System and the Texas Children's Hospital) in the Texas Medical Center in Houston. Cases were defined as those with a positive blood culture yielding Brucella sp or with a single positive serum tube agglutination titer ≥1:80, an epidemiologic risk factor, and clinical presentation and course consistent with brucellosis. Patient demographics, clinical features, and diagnostic evaluation and treatment data were recorded. When available, ethnicity was assigned by the patient's definition in the electronic medical record. We also recorded a history of any travel to an endemic area of brucellosis within 1 year before hospital admission. The normal ranges of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) at Ben Taub Hospital were 12 to 78 and 15 to 37 IU/L, respectively. For our pediatric cases, the normal range of ALT and AST depended on the patient's age and sex. Overall, normal ALT levels range from 6 to 55 IU/L and normal AST levels range from 10 to 45 IU/L at Texas Children's Hospital. As suggested by the American Society of Hematology, we defined thrombocytopenia as a platelet count <100,000/μL. 9 We compared adult and pediatric cases using the Mann-Whitney U test for continuous variables and the χ 2 test or Fisher exact test for categorical variables. P < 0.05 was considered statistically significant. All of the statistical analyses were conducted in STATA 12 (StataCorp, College Station, TX). The study protocol was approved by the institutional review board at the Baylor College of Medicine and administratively reviewed by the research office at both hospitals.
Results
Six adult and 12 pediatric cases were identified. The median age of the patients was 11 years (range, 21 months-61 years). The median age for adult patients was 52.5 years old, whereas the median age of pediatric patients was 2.9 years old. Fourteen of the 18 patients were Hispanic and the other 4 patients had no ethnicity documented. Thirteen patients had traveled to or lived in endemic countries: 11 patients were from Mexico, 1 was from Honduras, and 1 was from Kenya. The most common risk factor (seen in 14 of 18 patients) was ingestion of unpasteurized milk products. Five patients had exposure to farm animals. All of the patients were noted to have an epidemiologic risk factor for brucellosis. Table 1 outlines the patient demographics.
The most common clinical features included fever; arthralgias or arthritis; hepatomegaly, splenomegaly, or both; and night sweats ( Table 2) . Five of 18 patients had all three of the most common symptoms or signs (fever, arthralgias, hepatomegaly, or splenomegaly); all 18 patients had at least one of these symptoms. The most common laboratory finding was mildly elevated transaminases (Table 2) , which was seen in 83% (5 of 6) of adults and 75% (9 of 12) of children. Three adults but no children had thrombocytopenia (defined as platelets <100,000/μL) at the time of diagnosis (P = 0.02). Blood cultures were frequently positive in pediatric patients, but they were positive in only onethird of adults (83% vs 33%, P = 0.03). One patient had positive blood and synovial fluid cultures. Most cultures were speciated and identified as B melitensis. Eleven patients had a positive tube agglutination test for Brucella. Four patients-two adults and two children-were diagnosed by serology alone.
All of the patients received doxycycline or trimethoprim/ sulfamethoxazole-based combination antibiotic therapy, with the addition of rifampin, gentamicin, or both. The median duration of treatment was 42 days. Three pediatric and two adult patients received three-drug therapy, usually consisting of doxycycline (or trimethoprim/sulfamethoxazole), rifampin, and gentamicin. All of the patients experienced clinical improvement with initial antibiotic therapy; however, 6 of 10 patients who had documented follow-up visits developed relapse, which required a second treatment course. The remaining eight patients had incomplete documentation or were lost to follow-up. We did not appreciate any association between length or choice of therapy and relapse in those patients who had a follow-up visit.
Discussion
Epidemiologic risk factors for brucellosis were identified in all of our patients. Most of the patients were immigrants from Central America, which aligns with data from other studies and likely reflects immigration patterns to the United States. 5, 6 The relative paucity of cases in our series relates to the low incidence of the infection in Texas, which was calculated at 0.1 cases per 100,000 population in 2015. 10 Other epidemiological risk factors, which have been described in the literature, included ingestion of unpasteurized dairy products and exposure to farm and feral animals. 2, 5, 6, [11] [12] [13] [14] The most common clinical manifestations of brucellosis in our series were fever, arthralgias, arthritis, and hepatosplenomegaly. Less common clinical manifestations of brucellosis, including epididymo-orchitis, endocarditis, and neurological symptoms, 15 were not observed in our patients.
The most common laboratory abnormality was mildly elevated transaminases. Previous reports have underscored the fact that the symptoms and signs of brucellosis are varied and nonspecific. 4, 15 Brucellosis also is associated with hematologic manifestations, especially leukopenia, anemia, and thrombocytopenia. 16 We observed a higher rate of thrombocytopenia in our adult patients. A potential explanation for this difference is the strict definition of thrombocytopenia that we used (platelet count <100,000/μL). The overall incidence of thrombocytopenia in brucellosis has been reported to be between 1% and 8%. 17 In children with brucellosis, thrombocytopenia ranges between 2.6% and 16%. 16, 18 Thrombocytopenia seems to improve after the treatment of brucellosis. 17 The diagnosis of brucellosis requires isolation of Brucella sp on cultures (eg, blood, synovial fluid, bone marrow) or a positive serology in the setting of an appropriate clinical presentation and epidemiological risk factors. If brucellosis is suspected, then the clinician should notify the microbiology laboratory so that personnel can take appropriate precautions because of the risk of aerosol spread. Blood cultures have a sensitivity of 30% to 80%, depending on the culture method used. 19 Two pediatric studies found a positive blood culture rate of 86% to 90%. 7, 8 Combined adult and pediatric cases showed a positive blood culture rate of 68% to 82%. 6, 20 Although the rate of positive blood cultures in the children in our study (83%) is comparable to what was described previously, we found a much lower rate of positive blood cultures in adults (33%). One potential explanation is that pediatric cases had a relatively shorter duration of symptoms (21 days) than did the adult cases (120 days), suggesting that children were diagnosed earlier and during the bacteremic phase of the illness. In addition, it is a common practice in pediatrics to obtain blood cultures early in young children presenting with fever of unknown origin. 21 Although not all Brucella cultures were speciated, all of those that were speciated were identified as B melitensis, which is known to be the most common serotype of Brucella that causes human disease. 2 In accordance with current recommendations, 22 most patients received triple antibiotic therapy consisting of doxycycline or trimethoprim/sulfamethoxazole, with the addition of rifampin or gentamicin. Treatment of brucellosis is known to have a high rate of relapse, with some studies showing the relapse rate to be as high as 30%. 23 Our study has limitations. First, it is a retrospective review and therefore is dependent on the available documentation of history and physical findings. Second, some patients had incomplete follow-up data documentation. Third, the age distribution of our cases was not homogenous, given the inclusion of patients from two hospitals that treat either adult or pediatric patients. This may have led to an increase of cases in children, given the common practice to obtain blood cultures as part of diagnostic evaluation in young children who have fever without a focus. Fourth, Houston is an urban area in the southern United States; 
Conclusions
In the southern United States, brucellosis is an important consideration in the differential diagnosis of travelers and immigrants from Central or South America presenting with fever or joint complaints. Nonspecific laboratory abnormalities such as thrombocytopenia (in adults) and elevated transaminases may be present.
Patients should be asked specifically about the ingestion of unpasteurized dairy products because that is the most common epidemiologic link in the United States.
